Andrew Lewis, Ph. D.
About Andrew Lewis, Ph. D.
Andrew Lewis, Ph. D., is a scientist with expertise in cancer models and T-cell therapy. He has a background in bioengineering and biomedical sciences, having worked at institutions such as Mississippi State University, Baylor College of Medicine, and currently at Marker Therapeutics, Inc.
Work at Marker Therapeutics
Andrew Lewis, Ph.D., currently serves as a Scientist at Marker Therapeutics, Inc. in Houston, Texas. He has been with the company since 2022. His work focuses on the development of innovative therapies, particularly in the area of T-cell therapy for cancer treatment. This role allows him to apply his extensive knowledge in cancer models and molecular analyses to advance therapeutic strategies.
Education and Expertise
Andrew Lewis earned a Bachelor of Science degree in Bioengineering and Biomedical Engineering from Mississippi State University, where he studied from 2010 to 2014. He furthered his education at Baylor College of Medicine, obtaining a degree in Integrative Molecular and Biomedical Sciences from 2014 to 2019. His expertise includes cancer models, cell-based assays, and molecular analyses, which are critical in his research and development efforts.
Background
Andrew Lewis began his academic journey as a Student Research Volunteer at Mississippi State University from 2012 to 2014. This experience laid the groundwork for his subsequent studies and research. He then transitioned to Baylor College of Medicine, where he worked as a Graduate Student from 2015 to 2022. His time in these institutions provided him with a solid foundation in biomedical research and a focus on cancer therapies.
Achievements
During his academic career, Andrew Lewis focused on developing multi-tumor-associated antigen T-cell therapy for cancers. His research has contributed to advancements in cancer treatment methodologies. His work at both Mississippi State University and Baylor College of Medicine has equipped him with the skills necessary to make significant contributions in the field of biomedical sciences.